Cipla gets USFDA nod for rare genetic condition treatment drug

Cipla#39;s Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire#39;s Firazyr, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3epwuOn